查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1499564

肺癌手术市场：按手术设备、手术程序和最终用户划分 - 全球预测 2024-2030 年

Lung Cancer Surgery Market by Surgical Devices (Endo Surgical Equipment, Monitoring & Visualizing Systems, Surgical Instruments), Surgical Procedures (Minimally Invasive Surgeries, Thoracotomy), End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年肺癌手术市场规模为56.9亿美元，预计2024年将达60.1亿美元，2030年将达85亿美元，复合年增长率为5.88%。

肺癌手术是一种旨在透过切除肺部恶性和病变组织来治疗肺癌的医疗程序。当癌症局限于肺部的一个区域并且尚未广泛扩散到身体的其他部位时，通常会使用这种手术干预。肺癌手术的主要目标是根除全部或大部分癌细胞，从而治癒患者，或至少显着延长患者的生命并提高患者的生活品质。由于肺癌是全世界最常见的癌症之一，对有效手术介入的需求不断增加。这种不断上升的盛行率将透过增加对切除或缩小肿瘤的专门外科手术的需求来显着促进肺癌手术，最终迫使医疗保健系统适应，我们鼓励他们提供这些必要的服务。此外，各国政府也实施了有利的政策，促进创新手术设备和技术的核准流程。这些支持措施将有助于更快地将有效、安全的治疗方法推向市场，并扩大肺癌的治疗选择。然而，肺癌手术的高成本以及手术程序的标准化有限，构成了阻碍市场扩张的重大挑战。此外，微创手术技术和机器人辅助手术的发展取得了重大进展，为领先公司提供了新的途径。先进的机器人和人工智慧可以提高手术精度、减少人为错误并改善术后效果。

主要市场统计
基准年[2023] 56.9亿美元
预测年份 [2024] 60.1亿美元
预测年份 [2030] 85亿美元
复合年增长率（%） 5.88%

区域洞察

在美洲，美国和加拿大在肺癌盛行率和肺癌手术创新方面都占据重要地位。该地区拥有高度发展的医疗保健系统和较高的年度医疗支出，可以轻鬆获得先进的外科治疗。患者意识和高保险覆盖率正在推动视讯辅助胸腔镜手术 (VATS) 和机器人手术等微创手术的需求。该地区最近的专利通常侧重于增强这些微创手术并改善手术结果。同时，欧洲、中东和非洲国家展示了强大的政府支持的医疗保健系统，并积极参与肺癌研究网络。欧盟对医疗技术和研究的投资，例如地平线 2020 计划，对肺癌的手术技术和结果有直接影响。提供先进外科护理的全民健保系统进一步支持病患的治疗效果。此外，亚太地区肺癌患者数量正在显着增加。导致这一增长的因素包括某些国家的高吸烟率、都市区的空气污染以及人口的遗传倾向。发病率的增加推动了对有效肺癌治疗和手术的需求。亚太地区许多国家正积极加强医疗基础设施和能力。日本、韩国、澳洲和中国等国家正在医疗保健领域进行大量投资，包括现代化医疗设施以及培训专门从事肿瘤学和胸腔外科的医疗专业人员。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在肺癌手术市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对肺癌手术市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在肺癌手术市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肺癌发生率上升和吸烟趋势增加
      • 癌症的早期诊断和治疗变得越来越重要
      • 更多采用微创技术
    • 抑制因素
      • 肺癌诊疗费用高昂
    • 机会
      • 肺癌治疗技术进展
      • 癌症治疗的报销政策与政府支持
    • 任务
      • 缺乏训练有素的专业人员
  • 市场区隔分析
    • 手术设备：监测和可视化系统的技术进步可改善复杂的肺癌手术过程
    • 手术：肺癌微创手术因其减轻疼痛和恢復更快的优点而越来越受到青睐。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章肺癌手术市场手术设备

  • 末端手术设备
  • 监控及视觉化系统
  • 手术器械

第七章依手术方式分類的肺癌手术市场

  • 微创手术
  • 开胸手术

第八章肺癌手术市场：依最终用户分类

  • 医院
  • 专业癌症治疗中心

第九章北美及南美肺癌手术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太肺癌手术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲肺癌手术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 诺华收购 Mariana Oncology 增强癌症治疗能力
    • Harmonic 临床试验的扩展，东亚非吸烟者非小细胞肺癌治疗的新领域
    • 开创性的移植计画为第四期肺癌患者带来新的生命
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-501246436957

[187 Pages Report] The Lung Cancer Surgery Market size was estimated at USD 5.69 billion in 2023 and expected to reach USD 6.01 billion in 2024, at a CAGR 5.88% to reach USD 8.50 billion by 2030.

Lung cancer surgery is a medical procedure aimed at treating lung cancer by removing malignant tumors and affected tissues from the lungs. This surgical intervention is typically employed when the cancer is localized in one area of the lung and has not extensively spread to other parts of the body. The primary goal of lung cancer surgery is to eradicate all or most of the cancerous cells, potentially leading to a cure or at least a significant extension of lifespan and improvement in the quality of life of the patient. As lung cancer remains one of the most common types of cancer worldwide, the demand for effective surgical interventions continues to grow. This rise in prevalence significantly drives lung cancer surgery by increasing the need for specialized surgical procedures aimed at removing or reducing tumors, ultimately pushing healthcare systems to adapt and provide these necessary services. In addition, governments in various countries have been implementing favorable policies that expedite the approval process of innovative surgical devices and techniques. These supportive measures ensure that effective and safe tools reach the market sooner, facilitating enhanced treatment options for lung cancer. However, the high cost associated with lung cancer surgeries, along with the limited standardization during surgery procedures, is a significant challenge hindering market expansion. Moreover, significant progress in the development of minimally invasive surgical techniques and robotic-assisted surgery presents new avenues for key companies. Advanced robotics and artificial intelligence can improve precision in surgery, reduce human errors, and improve postoperative outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 5.69 billion
Estimated Year [2024] USD 6.01 billion
Forecast Year [2030] USD 8.50 billion
CAGR (%) 5.88%

Regional Insights

In the Americas, the United States and Canada are significant in both the prevalence of lung cancer and innovations in lung cancer surgery. The region's highly developed healthcare system and significant annual healthcare spending facilitate access to advanced surgical treatments. Patient awareness and high insurance coverage drive demand for minimally invasive surgeries, such as video-assisted thoracoscopic surgery (VATS) and robotic surgery. Recent patents in the region often focus on enhancing these minimally invasive techniques and improving surgical outcomes. At the same time, EMEA countries exhibit strong government-supported healthcare systems and active participation in lung cancer research networks. The EU's investment in health technology and research, such as the Horizon 2020 program, directly impacts lung cancer surgical techniques and outcomes. Patient outcomes are further supported by universal healthcare coverage, which provides access to advanced surgical care. Moreover, the Asia Pacific region has seen a significant uptick in the number of lung cancer cases. Factors contributing to this rise include high smoking rates in certain countries, urban air pollution, and genetic predispositions among populations. This increasing incidence has driven the demand for effective lung cancer treatments and surgeries. Many countries within the Asia Pacific region have been actively enhancing their healthcare infrastructures and capabilities. Nations such as Japan, South Korea, Australia, and China have made significant investments in healthcare, including modernizing medical facilities and training healthcare professionals specializing in oncology and thoracic surgery.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Lung Cancer Surgery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising incidence of lung cancer coupled with growing trend of smoking tobacco
      • Increasing emphasis on early diagnosis & treatment of cancers
      • Growing adoption of minimally invasive techniques
    • Market Restraints
      • High cost of lung cancer diagnosis & treatments
    • Market Opportunities
      • Rising technological advancements in lung cancer treatment
      • Availability of reimbursements policies and government support for cancer treatments
    • Market Challenges
      • Shortage of trained professionals
  • Market Segmentation Analysis
    • Surgical Devices: Technological advancements in the monitoring and visualizing systems to enhance the complex surgery procedures of lung cancer
    • Surgical Procedures: Growing preference for minimally invasive surgeries in lung cancer due to their adventages in reducing pain and fast recovery
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Lung Cancer Surgery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Lung Cancer Surgery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Novartis Enhances Cancer Treatment Capabilities with Acquisition of Mariana Oncology

Novartis has significantly advanced its position in the field of oncology by acquiring Mariana Oncology, a pioneering biotech firm based in Watertown, Massachusetts. This strategic move enriches Novartis' portfolio with innovative radioligand therapies (RLTs) targeting cancers that are notably difficult to treat. This acquisition enhances Novartis' research infrastructure and clinical supply capabilities and also aligns with its strategic priorities focusing on oncology and the innovation of its RLT platforms. [Published On: 2024-05-02]

Expansion of Harmonic Clinical Trial, A New Frontier in NSCLC Treatment for Never-Smokers in East Asia

Lantern Pharma has recently obtained regulatory approval to broaden the scope of its Phase II Harmonic clinical trial into Japan and Taiwan to evaluate LP-300, an innovative drug candidate, in combination with standard chemotherapy treatments pemetrexed and carboplatin for non-small cell lung cancer (NSCLC). This trial promises to fast-track the development and potential approval of LP-300 and also aligns with global efforts to provide targeted cancer therapies tailored to genetic profiles and demographic-specific risk factors. [Published On: 2024-04-23]

Pioneering Transplant Program Offers New Lease on Life for Stage 4 Lung Cancer Patients

In an innovative clinical initiative, Northwestern Medicine has launched the Double Lung Replacement and Multidisciplinary Care (DREAM) program, offering new hope through double-lung transplants for select stage 4 lung cancer patients whose disease is confined to the lungs and who have exhausted other treatment options. DREAM program transforms and extends lives through its focused, multidisciplinary approach as lung cancer remains the most lethal of cancers in the United States. [Published On: 2023-03-15]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Lung Cancer Surgery Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Lung Cancer Surgery Market, highlighting leading vendors and their innovative profiles. These include Accuray Inc., Ackermann Instrumente GmbH, AngioDynamics Inc., Baxter Healthcare Corporation, FusionKraft Surgical Instruments, Henry Schein, Inc., Intuitive Surgical Inc., Johnson & Johnson Services, Inc., KARL STORZ GmbH, Key Surgical LLC by STERIS plc, KLS Martin Group, Koninklijke Philips N.V., Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Scanlan International Inc., Siemens Healthineers AG, Sontec Instruments Inc., Teleflex Incorporated, TROKAMED GmbH, and Wexler Surgical Inc..

Market Segmentation & Coverage

This research report categorizes the Lung Cancer Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Surgical Devices
    • Endo Surgical Equipment
    • Monitoring & Visualizing Systems
      • Cameras & Video Support
      • Endoscopic Trocars with Optical Views
    • Surgical Instruments
      • Hand Instruments
        • Clamps
        • Cutters
        • Elevators
        • Foreceps
        • Retractors
        • Rib Shears
        • Scissors
        • Staplers
        • Trocar
      • Powered Surgical Equipment
  • Surgical Procedures
    • Minimally Invasive Surgeries
    • Thoracotomy
      • Lobectomy
      • Pneumenectomy
      • Segmentectomy
      • Sleeve Resection
  • End-user
    • Hospitals
    • Specialized Cancer Treatment Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of lung cancer coupled with growing trend of smoking tobacco
      • 5.1.1.2. Increasing emphasis on early diagnosis & treatment of cancers
      • 5.1.1.3. Growing adoption of minimally invasive techniques
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of lung cancer diagnosis & treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising technological advancements in lung cancer treatment
      • 5.1.3.2. Availability of reimbursements policies and government support for cancer treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of trained professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Surgical Devices: Technological advancements in the monitoring and visualizing systems to enhance the complex surgery procedures of lung cancer
    • 5.2.2. Surgical Procedures: Growing preference for minimally invasive surgeries in lung cancer due to their adventages in reducing pain and fast recovery
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Lung Cancer Surgery Market, by Surgical Devices

  • 6.1. Introduction
  • 6.2. Endo Surgical Equipment
  • 6.3. Monitoring & Visualizing Systems
  • 6.4. Surgical Instruments

7. Lung Cancer Surgery Market, by Surgical Procedures

  • 7.1. Introduction
  • 7.2. Minimally Invasive Surgeries
  • 7.3. Thoracotomy

8. Lung Cancer Surgery Market, by End-user

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Specialized Cancer Treatment Centers

9. Americas Lung Cancer Surgery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Lung Cancer Surgery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Lung Cancer Surgery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Novartis Enhances Cancer Treatment Capabilities with Acquisition of Mariana Oncology
    • 12.3.2. Expansion of Harmonic Clinical Trial, A New Frontier in NSCLC Treatment for Never-Smokers in East Asia
    • 12.3.3. Pioneering Transplant Program Offers New Lease on Life for Stage 4 Lung Cancer Patients
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. LUNG CANCER SURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. LUNG CANCER SURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. LUNG CANCER SURGERY MARKET DYNAMICS
  • FIGURE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. LUNG CANCER SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. LUNG CANCER SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LUNG CANCER SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDO SURGICAL EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDO SURGICAL EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CAMERAS & VIDEO SUPPORT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CAMERAS & VIDEO SUPPORT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDOSCOPIC TROCARS WITH OPTICAL VIEWS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDOSCOPIC TROCARS WITH OPTICAL VIEWS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CLAMPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CLAMPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CUTTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CUTTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ELEVATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ELEVATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY FORECEPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY FORECEPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RETRACTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RIB SHEARS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RIB SHEARS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY TROCAR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY TROCAR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY POWERED SURGICAL EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY POWERED SURGICAL EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY LOBECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY LOBECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PNEUMENECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PNEUMENECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SEGMENTECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SEGMENTECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SLEEVE RESECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SLEEVE RESECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SPECIALIZED CANCER TREATMENT CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SPECIALIZED CANCER TREATMENT CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 117. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 118. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 129. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 130. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 184. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 197. CHINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 198. CHINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 199. CHINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. CHINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 211. INDIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 212. INDIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 213. INDIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. INDIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 219. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 220. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 225. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 226. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 227. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 231. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 232. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 233. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 234. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 239. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 240. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 241. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 244. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 245. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 246. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 247. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 248. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 253. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 254. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 255. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 258. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 260. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 262. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 268. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 272. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 273. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 274. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 275. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 276. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 281. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 282. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 283. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 286. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 288. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 290. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 296. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 300. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 301. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 302. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 303. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 304. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 309. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 310. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 311. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 314. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 315. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 316. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 317. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 318. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 319. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 320. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 321. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 322. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 323. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 324. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 325. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 326. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 327. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 328. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 329. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MI